Biology Reference
In-Depth Information
References
Aerts L, Van Assche FA (2002) Taurine and taurine-deficiency in the perinatal period. J Perinat
Med 30:281-286
Airaksinen EM, Paljarvi L, Partanen J, Collan Y, Laakso R, Pentikainen T (1990) Taurine in
normal and diseased human skeletal muscle. Acta Neurol Scand 81:1-7
De Arcangelis V, Coletti D, Canato M, Molinaro M, Adamo S, Reggiani C, Naro F (2005)
Hypertrophy and transcriptional regulation induced in myogenic cell line L6-C5 by an increase
of extracellular calcium. J Cell Physiol 202:787-795
Gossett LA, Kelvin DJ, Sternberg EA, Olson EN (1989) A new myocyte-specific enhancer-bind-
ing factor that recognizes a conserved element associated with multiple muscle-specific genes.
Mol Cell Biol 9:5022-5033
Heller-Stilb B, van Roeyen C, Rascher K, Hartwig HG, Huth A, Seeliger MW, Warskulat U,
Haussinger D (2002) Disruption of the taurine transporter gene (taut) leads to retinal degenera-
tion in mice. FASEB J 16:231-233
Hosokawa Y, Matsumoto A, Oka J, Itakura H, Yamaguchi K (1990) Isolation and characterization
of a cDNA for rat liver cysteine dioxygenase. Biochem Biophys Res Commun 168:473-478
Ito T, Kimura Y, Uozumi Y, Takai M, Muraoka S, Matsuda T, Ueki K, Yoshiyama M, Ikawa M,
Okabe M, Schaffer SW, Fujio Y, Azuma J (2008) Taurine depletion caused by knocking out the
taurine transporter gene leads to cardiomyopathy with cardiac atrophy. J Mol Cell Cardiol
44:927-937
Iwata H, Obara T, Kim BK, Baba A (1986) Regulation of taurine transport in rat skeletal muscle.
J Neurochem 47:158-163
Jacobsen JG, Smith LH (1968) Biochemistry and physiology of taurine and taurine derivatives.
Physiol Rev 48:424-491
Kaisaki PJ, Jerkins AA, Goodspeed DC, Steele RD (1995) Cloning and characterization of rat
cysteine sulfinic acid decarboxylase. Biochim Biophys Acta 1262:79-82
Kook SH, Choi KC, Son YO, Lee KY, Hwang IH, Lee HJ, Chung WT, Lee CB, Park JS, Lee JC
(2008) Involvement of p38 MAPK-mediated signaling in the calpeptin-mediated suppression
of myogenic differentiation and fusion in C2C12 cells. Mol Cell Biochem 310:85-92
Maeda T, Gupta MP, Stewart AF (2002) TEF-1 and MEF2 transcription factors interact to regulate
muscle-specific promoters. Biochem Biophys Res Commun 294:791-797
Naya FJ, Olson E (1999) MEF2: a transcriptional target for signaling pathways controlling skeletal
muscle growth and differentiation. Curr Opin Cell Biol 11:683-688
Ramamoorthy S, Leibach FH, Mahesh VB, Han H, Yang FT, Blakely RD, Ganapathy V (1994)
Functional characterization and chromosomal localization of a cloned taurine transporter from
human placenta. Biochem J 15:893-900
Rothermel B, Vega RB, Yang J, Wu H, Bassel-Duby R, Williams RS (2000) A protein encoded
within the Down syndrome critical region is enriched in striated muscles and inhibits calcineu-
rin signaling. J Biol Chem 275:8719-8725
Semsarian C, Wu MJ, Ju YK, Marciniec T, Yeoh T, Allen DG, Harvey RP, Graham RM (1999)
Skeletal muscle hypertrophy is mediated by a Ca
2+
-dependent calcineurin signalling pathway.
Nature 400:576-581
Sturman JA (1993) Taurine in development. Physiol Rev 73:119-147
Sturman JA, Messing JM (1991) Dietary taurine content and feline reproduction and outcome.
J Nutr 121:1195-1203
Warskulat U, Flogel U, Jacoby C, Hartwig HG, Thewissen M, Merx MW, Molojavyi A, Heller-
Stilb B, Schrader J, Haussinger D (2004) Taurine transporter knockout depletes muscle taurine
levels and results in severe skeletal muscle impairment but leaves cardiac function uncompro-
mised. FASEB J 18:577-579
Yang J, Rothermel B, Vega RB, Frey N, McKinsey TA, Olson EN, Bassel-Duby R, Williams RS
(2000) Independent signals control expression of the calcineurin inhibitory proteins MCIP1
and MCIP2 in striated muscles. Circ Res 87:E61-E68
Search WWH ::
Custom Search